This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Axon Neuroscience GmbH
Drug Names(s): AADvac1
Description: AADvac1 is an active vaccine targeting Alzheimer tau, a novel pathological form of tau protein discovered by Axon. Alzheimer tau can prevent the formation of tau oligomers and neurofibrillary tangles and thus protect the brain from neurodegeneration.
Additional information available to subscribers only: